Study #2023-0421
Phase II study assessing efficacy and toxicity of Asciminib in patients with newly diagnosed chronic myeloid leukemia in chronic phase
MD Anderson Study Status
Enrolling
Treatment Agent
Asciminib
Description
To learn if asciminib can help to control CML. The safety and effects of this drug will also be studied.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Chronic Myeloid Leukemia
Study phase:
Phase II
Physician name:
Elias Jabbour
Department:
Leukemia
For general questions about clinical trials:
1-855-404-4637
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.